Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model
2024 · Pain · 23 citations
https://doi.org/10.1097/j.pain.0000000000003357
S
Santiago Loya‐López
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
323
Citations
11
h-index
11
i10-index
Santiago Loya‐López is an academic researcher from University of Arizona. The author has contributed to research in topics: Pain Mechanisms and Treatments & Ion channel regulation and function & Neuroscience and Neuropharmacology Research. The author has an h-index of 11, co-authored 37 publications.
ORCID: 0000-0001-6207-8370Papers by this author
worksIntranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain
2023 · Pain · 17 citations
https://doi.org/10.1097/j.pain.0000000000003053
The natural product argentatin C attenuates postoperative pain via inhibition of voltage‐gated sodium and T‐type voltage‐gated calcium channels
2022 · British Journal of Pharmacology · 14 citations
https://doi.org/10.1111/bph.15974
C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models
2024 · Journal of Clinical Investigation · 13 citations
https://doi.org/10.1172/jci177429
Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons
2022 · Neurobiology of Pain · 5 citations
https://doi.org/10.1016/j.ynpai.2022.100109
Mouse Models of Non-Dystrophic and Dystrophic Myotonia Exhibit Nociplastic Pain-like Behaviors
2025 · Journal of Pain · 0 citations
https://doi.org/10.1016/j.jpain.2025.104898
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat